Holden Comprehensive Cancer Center, University of Iowa

Iowa City, Iowa 52242

1 studies enrolling now · 7 studies all time

What they study most

Anaplastic Large-Cell Lymphoma, Anaplastic Thyroid Cancer, Breast Cancer, Colorectal Cancer, Esophageal Adenocarcinoma, Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer, Metastatic Solid Tumor, Monoclonal Antibody

Studies at this site

• A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer — Recruiting now
• Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors — Stopped early
• Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer — Completed
• A Safety Study of SEA-BCMA in Patients With Multiple Myeloma — Stopped early
• ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas — Completed
• A Safety Study of SGN-CD352A for Patients With Relapsed/Refractory Multiple Myeloma — Stopped early
• Healing Touch, Quality of Life, and Immunity During Breast Cancer Treatment — Completed